Menu
Home
About Us
Overview
Scientific president
Team
Board of directors
Intellectual property
Our Technology
SirVir
Aposense subsidiary in the field of respiratory viral infections
ATT-11T: Anti cancer pro-drug
On June 1st 2020 Aposense signed an agreement to license out the ATT-11T to Processa Pharmaceuticals
News
Contact Us
Close
Search for:
Careers
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.
Search for:
Home
About Us
▼
Overview
Scientific president
Team
Board of directors
Intellectual property
Our Technology
SirVir
▼
Aposense subsidiary in the field of respiratory viral infections
ATT-11T: Anti cancer pro-drug
▼
On June 1st 2020 Aposense signed an agreement to license out the ATT-11T to Processa Pharmaceuticals
News
Contact Us
Skip to content
Open toolbar
Accessibility Tools
Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset
